跳至主要内容
临床试验/JPRN-UMIN000049341
JPRN-UMIN000049341
已完成
未知

Validation of changes in autonomic nervous activity by a test-material consumption - Validation of changes in autonomic nervous activity by a test-material consumption

CPCC Company Limited0 个研究点目标入组 24 人2023年11月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Healthy male/female adults
发起方
CPCC Company Limited
入组人数
24
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年11月1日
结束日期
2022年11月2日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
CPCC Company Limited

入排标准

入选标准

  • 未提供

排除标准

  • (1\) Subjects being under some kind of continuous medical treatment. (2\) Subjects who have periodically used health\-specific / functional / health foods including supplements, which might affect the autonomic nervous system, metabolism and sleep. (3\) Subjects with incompatible eyeballs/eyelashes for pupillometry. (4\) Subjects with any hindrances to a pupil measurement (e.g., dry eye). (5\) Subjects having a subjective symptom of claustrophobia and nyctophobia. (6\) Subjects with nasal congestion and wrong judgement of fragrance. (7\) Subjects with excessive alcohol intake (not less than 60 g/day/week). (8\) Subjects with extremely irregular eating habits, and subjects having an irregular life rhythm with irregular shift work or midnight one. (9\) At the moment of informed consent, subjects who are under other clinical trials with some kind of medicine/food, or partook in those within four weeks before this trial. (10\) Subjects who are under a large stress condition with some kind of life event, such as house\-moving, transfer, bereavement, etc., within three months before the agreement for this trial. (11\) Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. (12\) Subjects with a serious symptom of premenstrual syndrome at the moment of this trial. (13\) Subjects who vaccinated within three days before this trial. (14\) Pregnant, possibly pregnant, and lactating women. (15\) Subjects having some kind of drug and/or food allergy. (16\) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

结局指标

主要结局

未指定

相似试验